Skip to main content

Early Stage Health Technology Assessment of eHealth solution for DiabetesExperience on the usage of the MAFEIP tool: data collection

  • Conference paper
  • First Online:
EMBEC & NBC 2017 (EMBEC 2017, NBC 2017)

Abstract

Evaluating eHealth solutions to improve the management of Diabetes requires a multidimensional perspective but, at the same time, there is need to converge the different dimensions in order to make decisions towards further stages of innovation. The work described in this paper informs on how the results of a European funded project have been re-elaborated in order to collect data for a cost-effectiveness analysis carried out through the MAFEIP tool that, since 2015, the European Commission has made available to assess innovations in health and social care for European regions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Martinez-Millana, A., Fico, G., Fernández-Llatas, C., and Traver, V. (2015). Performance assessment of a closed-loop system for diabetes management. Medical & biological engineering & computing, 1-9.

    Google Scholar 

  2. Fioravanti, A., Fico, G., Salvi, D., García-Betances, R. I., and Arredondo, M. T. (2015). Automatic messaging for improving patients engagement in diabetes management: an exploratory study. Medical & biological engineering & computing, 1-10.

    Google Scholar 

  3. Fico, G., Fioravanti, A., Arredondo, M. T., Gorman, J., Diazzi, C., Arcuri, G., Conti, C., and Pirini, G. (2016). Integration of Personalized Healthcare Pathways in an ICT platform for Diabetes Management: a small-scale exploratory study.

    Google Scholar 

  4. Fico, G., Fioravanti, A., Arredondo, M. T., Leuteritz, J. P., Guillén, A., & Fernandez, D. (2011). A user centered design approach for patient interfaces to a diabetes IT platform. In Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference (Vol. 2011, p. 1169). IEEE journal of biomedical and health informatics, 20(1), 29-38.

    Google Scholar 

  5. European Commission (2011). Strategic Implementation Plan for the European Innovation Partnership on Active and Healthy Ageing. Steering Group Working Document. Available here, last visit on April 2017.

    Google Scholar 

  6. Abadie F, Boehler C, Lluch M, Sabes-Figuera R, Zamora Talaya MB (2014). Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP). Second update of the process indicators European Commission Joint Research Centre, JRC91174.

    Google Scholar 

  7. Boehler C, Abadie F (2015). Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP). First report on a conceptual description of the monitoring framework. European Commission, Joint Research Centre European Commission.

    Google Scholar 

  8. Boehler et al (2015). Development of a web-based tool for the assessment of health and economic outcomes of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). BMC Medical Informatics and Decision Making, 15 (Suppl 3):S4

    Google Scholar 

  9. Birov, S. et al. MAFEIP User Guide, available at http://mafeip.eu/ Last visit on April, 2017

  10. European Commission, Managed Outcomes, Contract Number FP7-HEALTH-2009-3.2-2-241741, Available here, last visit on April 2017.

    Google Scholar 

  11. Mata, M., Antoñanzas, F., Tafalla, M., & Sanz, P. (2002). The cost of type 2 diabetes in Spain: the CODE-2 study. Gaceta Sanitaria, 16(6), 511-520.

    Google Scholar 

  12. Bottomley, J. M. (2001). Managing care of type 2 diabetes. Learnings from T2ARDIS. The British Journal of Diabetes & Vascular Disease, 1(1), 68-72.

    Google Scholar 

  13. Nwaneri, C., Cooper, H., & Bowen-Jones, D. (2013). Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis. The British Journal of Diabetes & Vascular Disease, 13(4), 192-207

    Google Scholar 

  14. Nicholas J, Charlton J, Dregan A, Gulliford MC (2013) Recent HbA1c Values and Mortality Risk in Type 2 Diabetes. Population-Based Case-Control, Study. PLoS ONE 8(7): e68008. doi:10.1371/journal.pone.0068008

  15. Arrieta, F., Rubio-Terrés, C., Rubio-Rodríguez, D., Magaña, A., Piñera, M., Iglesias, P. & Vázquez, C. (2014). Estimación del impacto económico y sanitario de las complicaciones de la diabetes mellitus tipo 2 en la Comunidad de Madrid. Endocrinología y Nutrición, 61(4), 193-201

    Google Scholar 

  16. Kanavos, P., van den Aardweg, S., & Schurer, W. (2012). Diabetes expenditure, burden of disease and management in 5 EU countries. LSE Health and social Care

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Fico .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this paper

Cite this paper

Fico, G., Lopez-Valverde, M., Arredondo, M.T. (2018). Early Stage Health Technology Assessment of eHealth solution for DiabetesExperience on the usage of the MAFEIP tool: data collection. In: Eskola, H., Väisänen, O., Viik, J., Hyttinen, J. (eds) EMBEC & NBC 2017. EMBEC NBC 2017 2017. IFMBE Proceedings, vol 65. Springer, Singapore. https://doi.org/10.1007/978-981-10-5122-7_248

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5122-7_248

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5121-0

  • Online ISBN: 978-981-10-5122-7

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics